TEM (Tempus AI) Quarterly Revenue Growth

TEM (Tempus) - company brandmark

Explosive demand for AI analytics in oncology contrasts with the success of Tempus AI, Inc (TEM) in forging alliances with clinics for therapy selection. Quarterly sales dynamics demonstrate this trend, while the 22.70 metric confirms the current level of development. However, high operating expenses and strict data protection regulations create serious risks for the business's financial stability.

Tempus AI, Inc. (TEM) - Sales Change QoQ from 06/15/2024 to 11/20/2026

TEM (Tempus): analytical breakdowns and indicator data

- current quotes and average value forecast:
Fundamental valuation:TEM - tempus.com
Mass-produced product of tempus.com

Quarterly revenue growth measures the rate of change in sales volume, reflecting the dynamics of market demand for the issuer's products. For Tempus AI, Inc (TEM), this metric confirms the effectiveness of aggressively expanding its genetic data base despite operating losses. By analyzing the quarterly revenue growth rate, an investor assesses the speed of business scaling under the leadership of the visionary. This metric serves as a key indicator of the viability of the expansion model.

Direct competitors

QGEN: Quarterly Sales Growth|Ionis Pharmaceuticals (IONS) - Quarterly Sales Growth|Repligen (RGEN) - Revenue Growth QoQ|Quarterly Sales Growth Avidity Biosciences, Inc.|Revenue Growth QoQ CRISPR Therapeutics|WGS - Revenue Change vs Previous Quarter|Quarterly Revenue Growth RARE|Sales Change QoQ BEAM|Quarterly Revenue Growth SRPT (Sarepta Corp)|TWST - Quarterly Sales Growth|TXG: Quarterly Sales Growth|Quarterly Revenue Growth Rate Intellia Therapeutics|STOK: Quarterly Revenue Growth|BLFS - Quarterly Sales Growth Rate|Quarterly Sales Growth WVE|MAZE: Quarterly Revenue Increase|Revenue Growth QoQ Sionna Corp (SION)|Quarterly Sales Growth Rate Prime Medicine Bio|Quarterly Revenue Growth TSHA (Taysha Gene Therapies Inc)|Quarterly Revenue Growth uniqure.com QURE|MeiraGTx Holdings - Quarterly Revenue Growth|RGNX - Quarterly Revenue Growth|SLDB (Solid Corp) - Quarterly Sales Growth|Revenue Change vs Previous Quarter Ocugen Corp OCGN|PACB (Pacific Biosciences) - Quarterly Revenue Growth|Revenue Growth QoQ BNTC|Quarterly Revenue Growth DSGN|Quarterly Sales Growth Rocket Pharma RCKT|Quarterly Sales Growth Rate FDMT|Quarterly Revenue Growth Lexeo Therapeutics LXEO|KRRO - Revenue Growth QoQ|EDIT (Editas Medicine, Inc.) - Sales Growth QoQ|SLN: Quarterly Revenue Growth|ProQR - Quarterly Revenue Increase|CDXS (Codexis) - Quarterly Revenue Growth|Sangamo (SGMO) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)